前往化源商城

148-53-8 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789871
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard Units
Activity=25ug
Activity=25ug
Activity=22ug
Activity=2.5ug
Activity=25ug
Activity=6ug
Activity=2.5ug
Activity=5ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789869
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeActivity Comment
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789868
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueActivity Comment
FC=1.5
FC=1.5
FC=1.5
FCNot Active
FC=1.5
FC=1.5
FCNot Active
FC=1.5
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789872
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard Units
Activity=3.5ug
Activity=3.5ug
Activity=3.5ug
Activity=2.5ug
Activity=3.5ug
Activity=3.5ug
Activity=2.5ug
Activity=3.5ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL936122
Protocol: N/A
Comment: Journal: J Biol Chem
Year: 2007
Volume: 282
Issue: 14
First Page: 10311
Last Page: 10324
DOI: 10.1074/jbc.m608207200
Standard TypeActivity Comment
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL936124
Protocol: N/A
Comment: Journal: J Biol Chem
Year: 2007
Volume: 282
Issue: 14
First Page: 10311
Last Page: 10324
DOI: 10.1074/jbc.m608207200
Standard TypeStandard RelationStandard ValueStandard UnitsData Validity Comment
Inhibition=209%Outside typical range
Inhibition=-13%Outside typical range
Inhibition=0.8%
Inhibition=-4.5%
Inhibition=89%
Inhibition=6.4%
Inhibition=0.9%
Inhibition=1.1%
Inhibition=2.9%
Inhibition=0.3%
Inhibition=3.9%
Inhibition=2.5%
Inhibition=1.4%
Inhibition=126%
Inhibition=68%
Inhibition=13%
Inhibition=0.7%
Inhibition=132%
Inhibition=26%
Inhibition=0.9%
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL936125
Protocol: N/A
Comment: Journal: J Biol Chem
Year: 2007
Volume: 282
Issue: 14
First Page: 10311
Last Page: 10324
DOI: 10.1074/jbc.m608207200
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityActive
ActivityActive
ActivityActive
ActivityNot Active
ActivityNot Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL936123
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: J Biol Chem
Year: 2007
Volume: 282
Issue: 14
First Page: 10311
Last Page: 10324
DOI: 10.1074/jbc.m608207200
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsData Validity Comment
26.06IC50=26060nM
2.58IC50=2580nM
67.6IC50=67600nM
11.48IC50=11480nM
106.87IC50=106870nMOutside typical range
10IC50=10000nM
361.11IC50=361110nMOutside typical range
244.16IC50=244160nMOutside typical range
122.19IC50=122190nMOutside typical range
31.64IC50=31640nM
426.25IC50=426250nMOutside typical range
0.25IC50=250nM
2787IC50=2787000nMOutside typical range
0.12IC50=120nM
0.09IC50=90nM
7.48IC50=7480nM
0.83IC50=830nM
25.51IC50=25510nM
1.87IC50=1870nM
15.94IC50=15940nM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789855
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=2
FC=10
FC=3
FC=4
FC=4
FC=2
FC=2
FC=3
FC=2
FC=5
FC=6
FC=10
FC=3
FC=12
FC=6
FC=10
FC=2
FC=7
FC=5
FC=8
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789854
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
MHC=10ug
MHC=50ug
MHC=15ug
MHC=20ug
MHC=20ug
MHC=10ug
MHCNot Active
MHC=10ug
MHC=15ug
MHC=10ug
MHC=25ug
MHC=30ug
MHCNot Active
MHC=50ug
MHC=15ug
MHCNot Active
MHC=60ug
MHC=30ug
MHC=50ug
MHC=10ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789853
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=3.2
FC=1
FC=3.2
FC=3.2
FC=3.2
FC=3.2
FC=1
FC=1
FC=1
FC=2.1
FC=1
FC=3.2
FC=1
FC=1
FC=2.1
FC=3.2
FC=2.1
FC=1
FC=2.1
FC=3.2
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789852
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
LD50Not Active
LD50=9ug
LD50=3ug
LD50Not Active
LD50=9ug
LD50Not Active
LD50Not Active
LD50Not Active
LD50=9ug
LD50Not Active
LD50Not Active
LD50=9ug
LD50Not Active
LD50=9ug
LD50Not Active
LD50Not Active
LD50=3ug
LD50=3ug
LD50=3ug
LD50=6ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL631694
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=2.26
LogP=0.64
LogP=1.71
LogP=2.1
LogP=0.97
LogP=1.37
LogP=0.65
LogP=1.35
LogP=0.59
LogP=2.7
LogP=0.9
LogP=-0.17
LogP=0.65
LogP=0.57
LogP=0.73
LogP=0.18
LogP=0.22
LogP=0.74
LogP=0.92
LogP=1.21
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789859
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
LD50Not Active
LD50=10ug
LD50Not Active
LD50Not Active
LD50=10ug
LD50Not Active
LD50Not Active
LD50Not Active
LD50Not Active
LD50Not Active
LD50Not Active
LD50=10ug
LD50Not Active
LD50=10ug
LD50Not Active
LD50Not Active
LD50Not Active
LD50Not Active
LD50=8ug
LD50Not Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL631695
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=0.5
LogP=-0.71
LogP=-0.01
LogP=0.74
LogP=0.74
LogP=1.87
LogP=-0.11
LogP=-0.55
LogP=0.15
LogP=1.74
LogP=1
LogP=-2.26
LogP=0.41
LogP=-0.05
LogP=1.01
LogP=0.53
LogP=-1.6
LogP=-0.08
LogP=-1.4
LogP=0.82
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789858
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=3.75
FC=1.25
FC=3.75
FC=2.5
FC=3.75
FC=1.25
FC=3.75
FC=1.25
FC=1.25
FC=2.5
FC=2.5
FC=1.25
FC=2.5
FC=2.5
FC=2.5
FC=3.75
FC=3.75
FC=1.25
FC=2.5
FC=3.75
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL875968
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=0
LogP=-1.54
LogP=-0.63
LogP=-0.03
LogP=0.04
LogP=1.4
LogP=-0.32
LogP=-1.7
LogP=0.04
LogP=0.99
LogP=0.6
LogP=-2.45
LogP=0.23
LogP=0.03
LogP=0.95
LogP=0.32
LogP=-2.56
LogP=-0.04
LogP=-2.31
LogP=0.2
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:BindingDB 靶标:N/A
External ID: BindingDB_6134_1
Protocol: N/A
Comment: Compounds with any of Ki, IC50, Kd, or EC50 activity value <= 10uM are labeled as "Active".
If multiple measurements are available for a given compound, it is labeled as "Active" if any of the measurements meet the criterion. Activity values are checked in the order of Ki, IC50, Kd, and EC50. The first entry that meets the above activity threshold is used to determine "Standard Type", "Standard Relation", and "PubChem Standard Value". Otherwise, the first non-empty entry will be used to set those values.
Standard TypeStandard RelationPubChem Standard ValueIC50 QualifierIC50Target Accession(s)LigandTarget
IC500.03434O75460BDBM110972Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.07979O75460BDBM110973Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.0880O75460BDBM110974Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.1100O75460BDBM110975Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.0880O75460BDBM110975Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.11110O75460BDBM110976Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.12120O75460BDBM110977Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.17170O75460BDBM110978Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.102102O75460BDBM110979Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.102102O75460BDBM110979Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110980Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110981Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.25250O75460BDBM110982Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.27270O75460BDBM110983Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.02222O75460BDBM110983Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.28280O75460BDBM110984Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.3300O75460BDBM110985Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.772772O75460BDBM110985Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.35350O75460BDBM110986Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.38380O75460BDBM110987Serine/threonine-protein kinase/endoribonuclease IRE1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789857
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
LD50Not Active
LD50=150ug
LD50=50ug
LD50Not Active
LD50=150ug
LD50Not Active
LD50Not Active
LD50Not Active
LD50=100ug
LD50Not Active
LD50Not Active
LD50=150ug
LD50=50ug
LD50=150ug
LD50Not Active
LD50Not Active
LD50=50ug
LD50=50ug
LD50=100ug
LD50=100ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL632430
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=0.58
LogP=0.11
LogP=0.62
LogP=1.38
LogP=1.18
LogP=2.3
LogP=0.34
LogP=-0.12
LogP=0.23
LogP=1.74
LogP=1.42
LogP=-1.6
LogP=1.43
LogP=0.81
LogP=1.8
LogP=1.16
LogP=-1.92
LogP=0.56
LogP=-0.89
LogP=1.42
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789856
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
LogP=1.24
LogP=0.97
LogP=2.39
LogP=1.15
LogP=1.48
LogP=1.87
LogP=1.76
LogP=1.47
LogP=1.44
LogP=1.15
LogP=1.48
LogP=1.48
LogP=1.47
LogP=3.19
LogP=1.19
LogP=1.47
LogP=2
LogP=1.15
LogP=1.19
LogP=1.15
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL632431
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=2.37
LogP=-0.22
LogP=1.51
LogP=1.28
LogP=0.82
LogP=1.35
LogP=0.53
LogP=1.1
LogP=0.38
LogP=1.77
LogP=0.85
LogP=-0.34
LogP=0.08
LogP=-0.07
LogP=0.93
LogP=0.43
LogP=0.37
LogP=0.11
LogP=1.31
LogP=0.96
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789863
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeActivity Comment
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
ActivityActive
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL632432
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1987
Volume: 30
Issue: 7
First Page: 1121
Last Page: 1126
DOI: 10.1021/jm00390a002
Standard TypeStandard RelationStandard Value
LogP=-0.57
LogP=-2.3
LogP=-2.22
LogP=-1.3
LogP=-0.85
LogP=0.53
LogP=-0.6
LogP=-0.95
LogP=0.05
LogP=0.3
LogP=-0.3
LogP=-3.06
LogP=-0.21
LogP=-0.48
LogP=0.29
LogP=-0.26
LogP=-3.14
LogP=-0.62
LogP=-2.72
LogP=-0.72
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789862
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=2
FC=2
FC=2
FC=2
FC=1
FC=1
FC=1
FC=1
FC=2
FC=3
FC=1
FC=2
FC=2
FC=1
FC=4
FC=3
FC=1
FC=1
FC=3
FC=2
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789861
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
MHC=10ug
MHC=10ug
MHC=10ug
MHC=10ug
MHC=5ug
MHC=5ug
MHCNot Active
MHC=5ug
MHC=5ug
MHC=10ug
MHC=15ug
MHC=5ug
MHC=10ug
MHC=10ug
MHC=5ug
MHCNot Active
MHC=20ug
MHC=15ug
MHC=5ug
MHC=5ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789860
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=2
FC=2
FC=2
FC=2
FC=1.6
FC=1.6
FC=2
FC=1.6
FC=2
FC=2
FC=2
FC=2
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789867
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueActivity Comment
FC=10
FC=10
FC=8.8
FCNot Active
FC=10
FC=2.4
FCNot Active
FC=2
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789866
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeActivity Comment
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789865
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard Units
Activity=10%
Activity=10%
Activity=10%
Activity=10%
Activity=10%
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789864
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard Units
Activity=40%
Activity=40%
Activity=40%
Activity=40%
Activity=40%
Activity=40%
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL891104
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Bioorg. Med. Chem.
Year: 2007
Volume: 15
Issue: 5
First Page: 2006
Last Page: 2015
DOI: 10.1016/j.bmc.2006.12.038
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard UnitsData Validity Comment
39810700IC50=3.981071705535E10nMOutside typical range
5750IC50=5750000nMOutside typical range
173780000IC50=1.7378008287494E11nMOutside typical range
3120IC50=3120000nMOutside typical range
323594000IC50=3.2359365692963E11nMOutside typical range
50500IC50=50500000nMOutside typical range
19952600IC50=1.995262314969E10nMOutside typical range
14200IC50=14200000nMOutside typical range
70794600IC50=7.079457843841E10nMOutside typical range
16250IC50=16250000nMOutside typical range
61659500IC50=6.165950018615E10nMOutside typical range
5900IC50=5900000nMOutside typical range
169824000IC50=1.6982436524617E11nMOutside typical range
5550IC50=5550000nMOutside typical range
181970000IC50=181970085861nMOutside typical range
42880IC50=42880000nMOutside typical range
23442300IC50=2.34422881532E10nMOutside typical range
13300IC50=13300000nMOutside typical range
75857800IC50=7.585775750292E10nMOutside typical range
29500IC50=29500000nMOutside typical range
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789851
Protocol: N/A
Comment: Journal: Eur. J. Med. Chem.
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard Value
FC=11.2
FC=2.6
FC=9.8
FC=11.2
FC=9.8
FC=9.8
FC=2.6
FC=2.6
FC=2.6
FC=8
FC=2.1
FC=9.8
FC=2.1
FC=4.9
FC=4.9
FC=11.2
FC=8
FC=2.6
FC=8
FC=9.8
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3789850
Protocol: N/A
Comment: Journal: Eur J Med Chem
Year: 2016
Volume: 114
First Page: 209
Last Page: 219
DOI: 10.1016/j.ejmech.2016.03.008
Standard TypeStandard RelationStandard ValueStandard UnitsActivity Comment
LD50Not Active
LD50=25ug
LD50=6ug
LD50Not Active
LD50=22ug
LD50Not Active
LD50Not Active
LD50Not Active
LD50=25ug
LD50Not Active
LD50Not Active
LD50=22ug
LD50Not Active
LD50=22ug
LD50Not Active
LD50Not Active
LD50=6ug
LD50=6ug
LD50=6ug
LD50=18ug
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:BindingDB 靶标:N/A
External ID: BindingDB_3284_1
Protocol: N/A
Comment: Compounds with any of Ki, IC50, Kd, or EC50 activity value <= 10uM are labeled as "Active".
If multiple measurements are available for a given compound, it is labeled as "Active" if any of the measurements meet the criterion. Activity values are checked in the order of Ki, IC50, Kd, and EC50. The first entry that meets the above activity threshold is used to determine "Standard Type", "Standard Relation", and "PubChem Standard Value". Otherwise, the first non-empty entry will be used to set those values.
Standard TypePubChem Standard ValueIC50Target Accession(s)LigandTarget
IC500.0440O75460BDBM110972Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.0880O75460BDBM110974Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.1100O75460BDBM110975Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.11110O75460BDBM110976Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.17170O75460BDBM110978Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110980Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110981Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.25250O75460BDBM110982Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.27270O75460BDBM110983Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.3300O75460BDBM110985Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.35350O75460BDBM110986Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.38380O75460BDBM110987Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.38380O75460BDBM110988Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.39390O75460BDBM110989Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.4400O75460BDBM110990Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.4400O75460BDBM110991Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.4400O75460BDBM110992Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.41410O75460BDBM110993Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.44440O75460BDBM110994Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.51510O75460BDBM110995Serine/threonine-protein kinase/endoribonuclease IRE1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL1110735
Protocol: N/A
Comment: Journal: Bioorg Med Chem Lett
Year: 2009
Volume: 19
Issue: 17
First Page: 4952
Last Page: 4957
DOI: 10.1016/j.bmcl.2009.07.082
Standard TypeActivity Comment
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL1110734
Protocol: N/A
Comment: Journal: Bioorg Med Chem Lett
Year: 2009
Volume: 19
Issue: 17
First Page: 4952
Last Page: 4957
DOI: 10.1016/j.bmcl.2009.07.082
Standard TypeActivity Comment
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityNot Active
ActivityActive
ActivityNot Active
ActivityNot Active
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:DTP/NCI 靶标:N/A
External ID: MCF7_OneDose
Protocol: NCI-60 Human Tumor Cell Lines Screen was performed using the standard one-dose NCI protocol, which is described in more detail at https://dtp.cancer.gov/discovery_development/nci-60/default.htm.

Compounds with GIPRCNT values below 10 were considered active. Activity score was based on GIPRCNT using the following formula:
max(-GIPRCNT/2 + 50, 0)
Score is 0 for GIPRCNT values of 100 or above, 50 for GIPRCNT values of 0, and 100 for GIPRCNT values of -100.
Comment: These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI National Service Center (NSC) number, which is contained in the
PUBCHEM_EXT_DATASOURCE_REGID field. In the NCI cell line identification system, MCF7 is panel number 5, cell number 1. PANELCODE or PANELNAME identify the NCI-60 cell panel. PANELNBR does NOT identify the NCI-60 panel.

EXPID is the NCI internal tracking number for the experiment identifier, and PREFIX = 'S' for the NSCs submitted through the NCI Chemical Agents repository.

Substance concentration unit is indicated in the data table, using the following abbreviations: M = molar (M), u = micrograms/milliliter (microg/mL), V = volumetric fraction.

M_GIPRCNT represents the mean growth percent for that experiment, and N_GIPRCNT indicates the number of values for that NSC within an experiment, while STDEV_GIPRCNT is the standard deviation. Most NSCs are tested once per experiment, resulting in EXP_COUNT = 1.
EXPIDPREFIXCONCENTRATION_UNITCONCENTRATIONPANELNBRCELLNBRPANELNAMECELLNAMEPANELCODEM_GIPRCNTN_GIPRCNTSTDDEV_GIPRCNTEXP_COUNT
2106OS49SM1.0E-551Breast CancerMCF7BRE88.231101
2106OS49SM1.0E-551Breast CancerMCF7BRE87.1119101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.4371101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.7113101
2106OS49SM1.0E-551Breast CancerMCF7BRE97.2463101
2106OS49SM1.0E-551Breast CancerMCF7BRE90.0129101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.7031101
2106OS49SM1.0E-551Breast CancerMCF7BRE30.8539101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.2896101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.8526101
2106OS49SM1.0E-551Breast CancerMCF7BRE83.1036101
2106OS49SM1.0E-551Breast CancerMCF7BRE84.2194101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.3237101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.6034101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.6643101
2106OS52SM1.0E-551Breast CancerMCF7BRE91.2503101
2106OS52SM1.0E-551Breast CancerMCF7BRE94.8714101
2106OS52SM1.0E-551Breast CancerMCF7BRE93.7372101
2106OS52SM1.0E-551Breast CancerMCF7BRE112.6132101
2106OS52SM1.0E-551Breast CancerMCF7BRE73.375101
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:DTP/NCI 靶标:N/A
External ID: IGROV1_OneDose
Protocol: NCI-60 Human Tumor Cell Lines Screen was performed using the standard one-dose NCI protocol, which is described in more detail at https://dtp.cancer.gov/discovery_development/nci-60/default.htm.

Compounds with GIPRCNT values below 10 were considered active. Activity score was based on GIPRCNT using the following formula:
max(-GIPRCNT/2 + 50, 0)
Score is 0 for GIPRCNT values of 100 or above, 50 for GIPRCNT values of 0, and 100 for GIPRCNT values of -100.
Comment: These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI National Service Center (NSC) number, which is contained in the
PUBCHEM_EXT_DATASOURCE_REGID field. In the NCI cell line identification system, IGROV1 is panel number 6, cell number 10. PANELCODE or PANELNAME identify the NCI-60 cell panel. PANELNBR does NOT identify the NCI-60 panel.

EXPID is the NCI internal tracking number for the experiment identifier, and PREFIX = 'S' for the NSCs submitted through the NCI Chemical Agents repository.

Substance concentration unit is indicated in the data table, using the following abbreviations: M = molar (M), u = micrograms/milliliter (microg/mL), V = volumetric fraction.

M_GIPRCNT represents the mean growth percent for that experiment, and N_GIPRCNT indicates the number of values for that NSC within an experiment, while STDEV_GIPRCNT is the standard deviation. Most NSCs are tested once per experiment, resulting in EXP_COUNT = 1.
EXPIDPREFIXCONCENTRATION_UNITCONCENTRATIONPANELNBRCELLNBRPANELNAMECELLNAMEPANELCODEM_GIPRCNTN_GIPRCNTSTDDEV_GIPRCNTEXP_COUNT
0809OS51SM1.0E-5610Ovarian CancerIGROV1OVA89.6274101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA94.0185101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA77.1805101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA76.1686101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA82.5618101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA88.7561101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA83.5845101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA92.7497101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA70.9555101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA58.7306101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA72.6041101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA90.3839101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA110.2345101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA97.6538101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA93.7697101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA56.4618101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA80.8893101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA79.078101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA-20.3008101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA72.0949101
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:BindingDB 靶标:N/A
External ID: BindingDB_7561_1
Protocol: N/A
Comment: Compounds with any of Ki, IC50, Kd, or EC50 activity value <= 10uM are labeled as "Active".
If multiple measurements are available for a given compound, it is labeled as "Active" if any of the measurements meet the criterion. Activity values are checked in the order of Ki, IC50, Kd, and EC50. The first entry that meets the above activity threshold is used to determine "Standard Type", "Standard Relation", and "PubChem Standard Value". Otherwise, the first non-empty entry will be used to set those values.
Standard TypeStandard RelationPubChem Standard ValueIC50 QualifierIC50Target Accession(s)LigandTarget
IC500.03434O75460BDBM110972Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.07979O75460BDBM110973Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.0880O75460BDBM110974Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.1100O75460BDBM110975Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.0880O75460BDBM110975Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.11110O75460BDBM110976Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.17170O75460BDBM110978Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.17170O75460BDBM110979Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.102102O75460BDBM110979Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110980Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.24240O75460BDBM110981Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.25250O75460BDBM110982Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.27270O75460BDBM110983Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.02222O75460BDBM110983Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.28280O75460BDBM110984Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.3300O75460BDBM110985Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.772772O75460BDBM110985Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.35350O75460BDBM110986Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.38380O75460BDBM110987Serine/threonine-protein kinase/endoribonuclease IRE1
IC500.38380O75460BDBM110988Serine/threonine-protein kinase/endoribonuclease IRE1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL4053389
Protocol: N/A
Comment: Journal: J Nat Prod
Year: 2017
Volume: 80
Issue: 2
First Page: 278
Last Page: 289
DOI: 10.1021/acs.jnatprod.6b00643
Standard TypeStandard RelationStandard ValueStandard Units
Inhibition=77.3%
Inhibition=7.5%
Inhibition=81.3%
Inhibition=18.5%
Inhibition=5.5%
Inhibition=37.8%